Prot# 111JC101: A Randomized, Rater-Blinded Study to Explore the Effect of Mefloquine in Subjects with Progressive Multifocal Leukoencephalopathy (PML)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/27/095/4/11

Funding

  • Biogen Inc. (111JC101)